Atrial Fibrillation and Cancer: Bidirectional Relationship and Potential for Personalized Care.

Area of Science:

• Cardiology
• Oncology
• Precision Medicine

Background:

• A known bidirectional relationship exists between cancer and atrial fibrillation (AF).
• Cancer and its treatments increase AF risk, while new-onset AF can predict malignancy.
• Novel anticancer agents present unique cardiotoxic effects, necessitating personalized AF management.

Purpose of the Study:

• To review the application of precision cardio-oncology for AF in cancer patients.
• To explore personalized approaches to AF screening, diagnosis, and management.
• To highlight the need for personalized interventions in clinical studies and routine care.

Main Methods:

• Review of current literature on cardio-oncology and AF.
• Focus on biomarkers, cardiac imaging, and risk stratification.
• Analysis of personalized interventions for AF in cancer patients.

Main Results:

• Precision cardio-oncology offers a tailored approach to AF management in cancer.
• Biomarkers and cardiac imaging are key tools for personalized screening and diagnosis.
• Personalized risk stratification is crucial for effective AF management.

Conclusions:

• A personalized approach to AF management is essential for cancer patients.
• Integrating precision cardio-oncology into clinical practice can improve patient outcomes.
• Further research and implementation of personalized interventions are needed.